This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides

TIDES TV Interview with Dr. Martin Rabel, Precision NanoSystems

Posted by on 09 February 2023
Share this article

Dr. Martin Rabel, a Senior Field Application Scientist at Precision NanoSystems, discusses how to accelerate the next generation of transformative medicines. Building on the success of the COVID-19 mRNA vaccine, lipid nanoparticles (LNPs) offer safe and effective ways to deliver nucleic acids enabling novel vaccines, cell and gene therapies.

Share this article